Programmable cells of monocytic origin as a source of osteochondroprogenitors: Effect of growth factors on osteogenic differentiation.
暂无分享,去创建一个
[1] Yan-Song Qi,et al. The Chondrogenic Potential of Progenitor Cells Derived from Peripheral Blood: A Systematic Review. , 2016, Stem cells and development.
[2] Y. Açil,et al. Isolation, characterization and investigation of differentiation potential of human periodontal ligament cells and dental follicle progenitor cells and their response to BMP-7 in vitro , 2015, Odontology.
[3] N. Hacohen,et al. Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells , 2016, Science.
[4] R. Brooks,et al. Peripheral Blood Mononuclear Cells Enhance Cartilage Repair in in vivo Osteochondral Defect Model , 2015, PloS one.
[5] Hui Shen,et al. Circulating monocytes: an appropriate model for bone-related study , 2015, Osteoporosis International.
[6] K. El-Sayed,et al. Pluripotency Gene Expression and Growth Control in Cultures of Peripheral Blood Monocytes during Their Conversion into Programmable Cells of Monocytic Origin (PCMO): Evidence for a Regulatory Role of Autocrine Activin and TGF-β , 2015, PloS one.
[7] Y. Açil,et al. Optimizing the osteogenic differentiation of human mesenchymal stromal cells by the synergistic action of growth factors. , 2014, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[8] A. Nussler,et al. Response to the “Enhancement of Human Peripheral Blood Mononuclear Cell Transplantation-Mediated Bone Formation” by Yang et al. , 2013, Cell transplantation.
[9] Tae-Jin Lee,et al. Enhancement of Human Peripheral Blood Mononuclear Cell Transplantation-Mediated Bone Formation , 2011, Cell transplantation.
[10] H. Yoshioka,et al. Sp7/Osterix is involved in the up-regulation of the mouse pro-α1(V) collagen gene (Col5a1) in osteoblastic cells. , 2010, Matrix biology : journal of the International Society for Matrix Biology.
[11] N. Reiling,et al. The generation of programmable cells of monocytic origin involves partial repression of monocyte/macrophage markers and reactivation of pluripotency genes. , 2010, Stem cells and development.
[12] T. Pufe,et al. Programmable cells of monocytic origin (PCMO): A source of peripheral blood stem cells that generate collagen type II‐producing chondrocytes , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[13] Robert E Guldberg,et al. Recent advances in gene delivery for structural bone allografts. , 2007, Tissue engineering.
[14] M. Kuwana,et al. Human circulating monocytes as multipotential progenitors. , 2007, The Keio journal of medicine.
[15] A. Montag,et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[16] Z. Trajanoski,et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation , 2007, BMC Genomics.
[17] N. Ishiguro,et al. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages , 2007, Acta orthopaedica.
[18] I. Springer,et al. Two techniques for the preparation of cell-scaffold constructs suitable for sinus augmentation: steps into clinical application. , 2006, Tissue engineering.
[19] A. Reinecke,et al. Multipotent Cells of Monocytic Origin Improve Damaged Heart Function , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] Marcus Abboud,et al. Bone graft versus BMP-7 in a critical size defect--cranioplasty in a growing infant model. , 2005, Bone.
[21] James A. Hutchinson,et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. , 2005, Gastroenterology.
[22] J. Hengstler,et al. Human Monocyte-Derived Neohepatocytes: A Promising Alternative to Primary Human Hepatocytes for Autologous Cell Therapy , 2005, Transplantation.
[23] Derrick E Rancourt,et al. Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: Effect of cofactors on differentiating lineages , 2005, BMC Developmental Biology.
[24] A. Seth,et al. Collagen, type V, α1 (COL5A1) is regulated by TGF-β in osteoblasts , 2004 .
[25] Y. Ikeda,et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation , 2003, Journal of leukocyte biology.
[26] I. Springer,et al. Culture of cells gained from temporomandibular joint cartilage on non-absorbable scaffolds. , 2001, Biomaterials.
[27] A. Flyvbjerg,et al. Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. , 2001, The Journal of endocrinology.
[28] Y. Açil,et al. Three-dimensional cultivation of human osteoblast-like cells on highly porous natural bone mineral. , 2000, Journal of biomedical materials research.
[29] V. Matkovic. Nutrition, genetics and skeletal development. , 1996, Journal of the American College of Nutrition.
[30] Subburaman Mohan,et al. Growth factors for bone growth and repair: IGF, TGFβ and BMP , 1996 .
[31] L. Bonewald,et al. Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long‐term cultures of fetal rat calvarial osteoblasts , 1994 .
[32] Subburaman Mohan,et al. Growth factors to stimulate bone formation , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] G. Stein,et al. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix , 1990, Journal of cellular physiology.
[34] R. Geha,et al. Clinical Immunology , 1972, The Lancet.
[35] Y. Açil,et al. Suppression of osteoblast-related genes during osteogenic differentiation of adipose tissue derived stromal cells. , 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[36] M. Longaker,et al. Tissue-Specific Progenitor and Stem Cells Peripheral Blood-Derived Mesenchymal Stem Cells : Candidate Cells Responsible for Healing Critical-Sized Calvarial Bone Defects , 2015 .
[37] E. Tobiasch,et al. Differentiation Potential of Adult Human Mesenchymal Stem Cells , 2011 .
[38] A. Seth,et al. Collagen, type V, alpha1 (COL5A1) is regulated by TGF-beta in osteoblasts. , 2004, Matrix biology : journal of the International Society for Matrix Biology.
[39] Gordana Vunjak-Novakovic,et al. Bone Tissue Engineering Using Human Mesenchymal Stem Cells: Effects of Scaffold Material and Medium Flow , 2004, Annals of Biomedical Engineering.
[40] I. Springer,et al. Effects of bone morphogenetic protein‐7 stimulation on osteoblasts cultured on different biomaterials , 2002, Journal of cellular biochemistry.
[41] M. Lind,et al. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. , 1998, Acta orthopaedica Scandinavica. Supplementum.
[42] S. Mohan,et al. Growth factors for bone growth and repair: IGF, TGF beta and BMP. , 1996, Bone.
[43] J. Lee,et al. Printed in U.S.A. Copyright © 1997 by The Endocrine Society Osteogenic Protein-1 and Insulin-Like Growth Factor I Synergistically Stimulate Rat Osteoblastic Cell Differentiation and Proliferation* , 2022 .